Juvena Therapeutics key facts
as of Oct 2026- Developer of a biopharmaceutical drug discovery platform intended to discover novel protein-based therapeutics.
- Juvena Therapeutics is valued at approximately $100.0M as of Oct 2026 (last reported valuation).
- It has raised $132.2M across 2 recorded rounds; the latest was Early Stage VC ($30.5M) in Jun 2025.
- Notable investors include Alumni Ventures, Creative Destruction Lab, Liquid 2 Ventures, Global Founders Capital, StartX (US) — 34 tracked in total.
- Juvena Therapeutics has filed 2 Form Ds with the SEC since 2018, most recently Jul 2025 ($30.5M sold to 12 investors).
- Status: Privately Held (backing).
Juvena Therapeutics's last reported valuation, Nov 2022. Nothing priced has surfaced since.
- ·The complete investor list: 34 names
- ·Watch Juvena Therapeutics: the Monday email on marks, rounds and moves
Juvena Therapeutics funding rounds
2 roundsWho backs Juvena Therapeutics
34+Juvena Therapeutics valuation
Juvena Therapeutics's last reported valuation was $100 million in Nov 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has Juvena Therapeutics raised?
Juvena Therapeutics has raised $132 million in total; 2 of its rounds are on record. The largest on record was a $4.3 million seed round in Feb 2018; the most recent was a $30.5 million early-stage round in Jun 2025.
Juvena Therapeutics has filed 2 Form Ds with the SEC since 2018, most recently in Jul 2025 ($30.5 million sold to 12 investors).
Juvena Therapeutics investors
34 investors are on record for Juvena Therapeutics, including Alumni Ventures, Creative Destruction Lab, Liquid 2 Ventures and Global Founders Capital. By type, the record holds 11 venture capital firms and 1 family office. The early-stage round in Jun 2025 drew 12 investors.
About Juvena Therapeutics
Developer of a biopharmaceutical drug discovery platform intended to discover novel protein-based therapeutics. The company's platform screens restored cellular functions to produce rejuvenating protein-based therapeutics that promote tissue regeneration and repair to treat chronic and rare diseases, enabling healthcare professionals to decode secreted proteins for chronic and age-related diseases.
- Sector
- Healthcare
- HQ
- Redwood City, CA, United States
- Founded
- 2017
- Employees
- 44
- Website
- juvenatherapeutics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.